supporting

3DHISTECH, of Budapest, makes the Pannoramic slide scanners, including the high-throughput Pannoramic 1000, and the SlideViewer software used in research and European clinical laboratories, distributed by Epredia and Thermo Fisher in some markets. As digital pathology consolidates around a few large vendors, holding its position is the open question.

Abzena is a bioconjugation and biologics CDMO with the ThioBridge site-specific linker technology.

ADC bioconjugation manufacturing joins a payload so toxic it needs the top containment class (OEB 5) to an antibody, then checks drug-to-antibody ratio and free payload. Capacity sits with a handful of contractors such as Lonza, WuXi XDC and Samsung Biologics, so long queues and China-based exposure shape who can develop ADCs.

Agilent makes the Dako PD-L1 IHC 22C3 and 28-8 companion diagnostics and the Omnis staining platform.

Software that draws organs and tumours on scans automatically, saving hours per patient and making daily plan adaptation practical.

AI compute platforms are the GPUs, model libraries, and cloud services that pathology, radiology, and drug-design AI run on.

Spatial proteomics (PhenoCycler, PhenoImager) used to map immune cells in tumours; agreed to be acquired by Quanterix (2025).

Leading GMP plasmid DNA and mRNA raw-material supplier, acquired by Danaher for $9.6B in 2021.

Making cell therapies from a healthy donor or stem-cell line in advance, so patients get an off-the-shelf product instead of waiting weeks.

Antibody manufacturing means growing antibody drugs like pembrolizumab or trastuzumab in vats of engineered hamster cells, then purifying them. It is the industrial base for most modern cancer drugs.

Apheresis is collecting a patient's white blood cells through a machine over several hours. Every autologous CAR-T begins here, and the quality of these cells shapes the final product.

German medical-device company supplying Celsite ports, Easypump elastomeric pumps, infusion systems, and cytotoxic-safe consumables.

Infusion pumps (Spectrum, Novum), elastomeric ambulatory pumps (Infusor), IV fluids and generic injectables.

Medical technology company supplying closed-system transfer devices (PhaSeal), infusion systems, flow cytometers, and single-cell tools.

Freezers full of consented tumour samples with matched clinical data, which every biomarker and drug programme depends on.

Maker of CryoStor freeze media used in most approved cell therapies, plus evo cold-chain shippers.

Boehringer Ingelheim BioXcellence is the contract-manufacturing arm of Boehringer Ingelheim, one of the largest antibody producers by volume.

Surgical navigation and radiosurgery planning software (Elements), used in neurosurgery and stereotactic radiotherapy.

Scientific-instrument group that acquired NanoString (GeoMx, CosMx) out of bankruptcy in 2024 to form Bruker Spatial Biology.

Imaging core lab and RTSM provider (formerly Parexel Informatics), a leading vendor of blinded central review in oncology trials.

The public systems that count every cancer diagnosis and death in a country, which tell us whether incidence and survival are improving.

Curated databases that say what each mutation means for treatment, and the expert meetings that use them to decide on therapy.

Canon Medical is the Japanese imaging vendor (formerly Toshiba Medical) with CT, MRI, ultrasound, and the Cartesion Prime PET/CT.

Nuclear pharmacy network (>130 sites) that compounds and delivers SPECT and PET doses, and a distributor of oncology drugs to community practices.

Catalent, of Somerset, New Jersey, is a contract manufacturer that fills and finishes sterile injectables and makes biologics and cell and gene therapies; Novo Holdings bought it in 2024 and moved three sites to Novo Nordisk. The diversion of fill-finish capacity to obesity drugs may squeeze oncology products.

Scheduling and tracking software that makes sure each patient's cells come back to that patient, on time.

The quality checks a CAR-T batch must pass before it can be given: sterile, correct identity, enough live CAR-positive cells, and no replicating virus.

Cellares builds the Cell Shuttle, a fully automated 'smart factory' for cell therapies, with BMS and Kite as partners.

Preclinical CRO for safety and discovery studies, with viral vector and cell-therapy manufacturing services.

Non-profit generic drug maker formed by hospital systems to secure supply of essential injectables, including oncology drugs.

Clario is the endpoint technology company (Bioclinica and ERT merger) for imaging, eCOA, and cardiac data in trials.

Software that turns raw sequencer output into a report of which mutations matter and which drugs they point to.

Clinical trial software is the set of systems that collect trial data, randomise patients, and keep every form auditable.

Sealed, robot-run machines that turn a patient's blood cells into a CAR-T product with far fewer hands, clean rooms, and mistakes.

Comecer, of Castel Bolognese, Italy, and part of ATS Corporation, makes hot cells, isolators and dose calibrators, the shielded enclosures and automation that radiopharmacies need to handle radioactive drugs aseptically. Therapeutic radioligands need more shielding than diagnostic tracers, and whether hospitals build enough of it is the open question.

The clinics where most cancer patients are actually treated, increasingly organised into large networks that also run trials.

Oncology real-world data and AI company (ex-CancerLinQ data partner), supplying pharma and FDA-facing studies.

Companies that run clinical trials for sponsors: sites, monitoring, data, and regulatory filing.

Curated oncology real-world data with clinically abstracted endpoints, used in FDA-recognised RWE studies.

Cryoport is a specialist cryogenic logistics provider supporting most commercial CAR-T products and hundreds of cell-therapy trials.

Freezing cells at minus 150 degrees and shipping them in liquid-nitrogen 'dry shippers' with tracking, so a living drug arrives alive and matched to the right patient.

Danaher's bioprocessing arm (formerly GE Healthcare Life Sciences), supplying the Sefia cell-therapy platform, chromatography, and single-use systems.

Privacy-preserving record linkage (tokenisation) that lets real-world datasets be joined without exposing identities.

Running parts of a trial at home or locally, with telehealth, home nursing, and remote monitoring, so patients far from big centres can take part.

Discovery Life Sciences is a large commercial biospecimen and biomarker services provider (tissue, blood, cells) for pharma and diagnostics.

DNAnexus, of Mountain View, California, runs the secure genomics cloud platform behind the UK Biobank Research Analysis Platform and Genomics England, giving biobanks, drug companies and clinical laboratories a compliant place to store and analyse sequencing data. Whether such trusted environments open data to more researchers without weakening privacy is what those deployments test.

German isotope and radiopharmaceutical services company supplying Lu-177, Ga-68 generators, Ac-225 development, and contract manufacturing.

Apps and sensors that let patients report symptoms between visits, which in trials improved survival and cut emergency visits.

AVITI benchtop sequencer with avidity chemistry, competing on accuracy and cost with mid-throughput Illumina systems.

Epic Systems is the dominant US hospital EHR; its Beacon oncology module handles chemotherapy ordering and Cosmos aggregates de-identified records for research.

Federated learning trains one AI model across hospitals by exchanging model updates, not patient data, so a pathology or radiology model learns from every site while records stay behind each firewall. Owkin, NVIDIA FLARE and the MELLODDY pharma consortium use it; governance overhead and differing data across sites are the practical obstacles.

Oncology EHR (OncoEMR) and the largest curated real-world oncology database, acquired by Roche for $1.9B in 2018.

Florida Cancer Specialists is one of the largest independent oncology practices in the US and a leading phase 1 enroller through its Drug Development Unit.

Fortrea, of Durham, North Carolina, is the contract research organisation spun out of Labcorp in 2023 that runs clinical trials for sponsors and keeps ties to Labcorp's central laboratory, which handles trial samples. Competing for oncology programmes against much larger rivals without its parent's balance sheet is its open question.

Fresenius Kabi, of Bad Homburg, Germany, supplies the Amicus and LOVO apheresis devices that collect and process cells for cell therapy, a large portfolio of generic chemotherapy injectables, biosimilars and infusion products. Its generics have filled gaps during injectable shortages, which keep recurring because the economics of generic injectables remain unfixed.

FUJIFILM Diosynth Biotechnologies, headquartered in Tokyo, is a biologics contract manufacturer offering mammalian and microbial production and cell and gene therapy services, and is adding antibody capacity in Denmark and North Carolina, where its Holly Springs site is among the world's largest. Whether new capacity outruns demand once the biggest antibody patents expire is the sector's question.

Galapagos is a biotech pursuing decentralised, seven-day vein-to-vein CAR-T manufacturing at hospital sites; it restructured its cell-therapy business in 2025.

Keeping cheap, essential chemotherapy drugs like cisplatin available; shortages in 2023 forced rationing in US hospitals.

Cloud systems where hospitals and researchers store and analyse genomic data securely at petabyte scale.

Alphabet's health efforts: mammography and pathology AI research, Med-PaLM/MedGemma medical models, DeepMind's AlphaFold, and Isomorphic Labs drug design.